Literature DB >> 1540032

Presence of paf-acether in rheumatic diseases.

P Hilliquin1, C J Menkes, S Laoussadi, J Benveniste, B Arnoux.   

Abstract

Paf-acether (paf) is a naturally occurring phospholipid involved in inflammatory processes. The presence of paf, its precursor lyso paf, and lipo-paf has been determined in blood and synovial fluid from 13 patients with rheumatoid arthritis (RA), 11 with spondylarthropathies, eight with other inflammatory rheumatisms, 13 with chondrocalcinosis, 15 with osteoarthritis, and also in blood from nine healthy subjects. Paf and lipo-paf were measured by rabbit platelet aggregation after isolation by high performance liquid chromatography, whereas lyso paf was first chemically acetylated to give paf. Lipo-paf in blood was higher in patients than in controls; lipo-paf concentrations in blood and in synovial fluid were significantly higher in rheumatoid arthritis than in osteoarthritis and chondrocalcinosis. By contrast, paf and lyso paf reached their lower values in rheumatoid arthritis. The amounts of lipid mediators were not correlated with biological parameters of inflammation. Lipo-paf, which is considered as a storage form of paf, may be the important form of paf in active inflammatory rheumatism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540032      PMCID: PMC1004613          DOI: 10.1136/ard.51.1.29

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes.

Authors:  P Salem; S Deryckx; A Dulioust; E Vivier; Y Denizot; C Damais; C A Dinarello; Y Thomas
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

2.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

Review 3.  Mediators of rheumatoid arthritis.

Authors:  B Henderson; E R Pettipher; G A Higgs
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

4.  Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.

Authors:  J Benveniste; D Nunez; P Duriez; R Korth; J Bidault; J C Fruchart
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

5.  Letter: Aggregation of human platelets by platelet-activating factor.

Authors:  J Benveniste; J P Le Couedic; P Kamoun
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

6.  Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.

Authors:  B M Czarnetzki; J Benveniste
Journal:  Chem Phys Lipids       Date:  1981-12       Impact factor: 3.329

7.  Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

Authors:  J M Dayer; B de Rochemonteix; B Burrus; S Demczuk; C A Dinarello
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

9.  PAF-acether in chronic arthritis.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Agents Actions       Date:  1987-06

10.  Release, purification, and characterization of platelet-activating factor (PAF).

Authors:  V Tencé; J Polonsky; J P Le Couedic; M J Benveniste
Journal:  Biochimie       Date:  1980       Impact factor: 4.079

View more
  5 in total

1.  Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis.

Authors:  P Hilliquin; A Dulioust; C Gregoir; A Arnoux; C J Menkés
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

2.  Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.

Authors:  P Hilliquin; J Natour; J Aissa; P Guinot; S Laoussadi; J Benveniste; C J Menkes; B Arnoux
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

3.  IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells.

Authors:  S Gutierrez; I Palacios; J Egido; P Zarco; R Miguelez; E González; G Herrero-Beaumont
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

4.  Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases.

Authors:  P Vergne; V Praloran; R Treves; Y Denizot
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

5.  Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis.

Authors:  Teresia M Osborn; Margareta Verdrengh; Thomas P Stossel; Andrej Tarkowski; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2008-09-27       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.